素材紹介 新規分岐オリゴ糖「日食ブランチオリゴ」とその他オリゴ糖製品の紹介

Saracatinib is a highly selective Src kinase inhibitor against all Src kinase family members and has demonstrated anticancer effects in preclinical models. Unfortunately, it has shown multiple adverse effects during its clinical trials, along with time-dependent inhibition of P450 enzymes. The major... View More